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Abstract: 
Purpose: Social prescribing are short-term intermediary services that facilitate patients with 
psychosocial needs to engage in non-clinical support. However little is known about the 
components and potential impact of social prescribing. 
Design/methodology/approach: A review was conducted to explore the evidence base on 
social prescribing including mapping its key components and potential impact. Database, 
internet and hand searching was utilised to identify relevant studies. Data extraction and 
narrative analysis was undertaken to explore the issues. 
Findings: Twenty-four studies met the inclusion criteria. The studies were diverse in their 
methodologies and the services evaluated. Stakeholders such as general practitioners and 
SDWLHQWVSHUFHLYHGWKDWVRFLDOSUHVFULELQJLQFUHDVHGSDWLHQWV¶PHQWDOZHOO-being and decreased 
health service use. However the quantitative evidence supporting this was limited. The only 
randomised controlled trial showed a decrease in symptoms and increase in functional well-
being at four months. The other non-controlled designs had large drop-out rates limiting their 
value in determining effectiveness.  
Research limitations/implications: Further research is needed on the effectiveness and cost 
effectiveness of social prescribing using robust evaluative designs. 
Originality/value: This is the first review of generic social prescribing services focusing on 
the general evidence base. 
 
Keywords: Social prescribing, psychosocial needs, social support, community referral 
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Main Article 
(1) Introduction 
General Practitioners (GPs) report that over 20% of consultations involve dealing with 
SDWLHQWV¶SV\FKRVRFLDOQHHGVZantinge et al., 2005). Psychosocial needs are emotional, social 
RUSV\FKRORJLFDOQHHGVZKLFKPD\GHWULPHQWDOO\DIIHFWDSDWLHQW¶VKHDOWKIRUH[DPSOHVRFLDO
isolation or low self-esteem. GPs can feel unable to manage these because of time constraints, 
a limited knowledge of available support and because referral to traditional psychological 
services may not be appropriate (Zantinge et al., 2005). 
3ROLFLHVVXFKDVµ6DYLQJ/LYHV2XU+HDOWKLHU1DWLRQ¶'HSDUWPHQWRI+HDOWKDGYRFDWH 
utilising community support structures to help manage psychosocial problems. In part, this is 
motivated by the need for the National Health Service (NHS) to develop alternatives to 
clinical primary care services because of increased demand and budgetary freezes (Curry et 
al., 2011). However it also reflects current strategies which encourage patients to develop 
self-management techniques such as good social support (Gallant, 2003). One such 
intervention is social prescribing, which helps patients to access non-clinical sources of 
support primarily, but not exclusively, within the community sector (South et al., 2008).  
 
Whilst there are different models of social prescribing, this article focuses on generic 
supported referral schemes based in primary care, such as those in Sheffield and Bradford. 
Patients are usually referred by a health professional to meet for a limited number of 
appointments with a facilitator, often termed a social prescriber. They will identify and 
VXSSRUWWKHSDWLHQW¶VHQJDJHPHQWLQQRQ-clinical support that could meet their psychosocial 
needs (Keenaghan et al, 2012). For example, a patient who is socially isolated may be 
supported to engage in a lunch club. Social prescribing services are often based in General 
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Practices but delivered by community organisations. Social prescribing differs from services 
such as social work because it is an intermediary to facilitate the patient to access support 
rather than providing that support.  
 
Reviews of specific initiatives such as exercise on prescription have found that services are 
beneficial. For example exercise levels increased by 10% amongst patients receiving an 
exercise on prescription service (Sørensen et al., 2006). However, there has been no 
comprehensive review of generic social prescribing services. Therefore the aim of this review 
was to map the evidence on generic social prescribing schemes and their potential impact.  
 
 
 (2) Methods 
2.1 Review method 
A review was conducted to identify the range of evidence on social prescribing. This 
involved the use of rigorous methods to identify and analyse relevant literature (Armstrong et 
al, 2011). Unlike systematic reviews, no formal quality appraisal of each study was 
undertaken because the aim was to map the overall evidence base.  
 
2.2 Search strategy 
There are no defined search terms for social prescribing, so a range was utilised in various 
FRPELQDWLRQVLQFOXGLQJµVRFLDOSUHVFULELQJ¶µFRPPXQLW\UHIHUUDO¶µVRFLDOVXSSRUW¶
µSV\FKRVRFLDO¶µVRFLDOZRUN¶µSULPDU\FDUH¶µYROXQWDU\VHFWRU¶DQG µWKLUGVHFWRU¶%RROHDQ
operators and different truncations of the terms were utilised. These terms were used in a 
search of OVID SP, Open Grey, CINAHL, ASSIA, the Kings Foundation and Science 
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Citation Index Web of Knowledge. To capture grey literature, an internet search was 
FRQGXFWHGXVLQJ*RRJOH7KHVHDUFKWHUPµVRFLDOSUHVFULELQJ¶ZDVused because it was the 
most relevant term when performing the database search. Hand searching was undertaken of 
the following journals for 2011-2013: Primary Health Care Research and Development; 
British Journal of General Practice; Journal of Public Mental Health and Patient Education 
and Counseling. This time frame was chosen because earlier articles were likely to be 
referenced by later studies. The websites of relevant organisations were searched to identify 
potential literature. References of included studies were searched to identify other research.  
 
2.3 Selection criteria 
The search was limited to literature written in English and literature published between 1993 
and 2013. Studies had to focus on primary care based social prescribing services which 
encompassed the description in the introduction. Primary research, evaluations, reviews and 
policy documents were included. Promotional information on specific services was excluded.  
 
2.4 Data extraction 
A data extraction form was developed to obtain consistent information about each study. 
Narrative synthesis was used to summarise the findings of the studies. The review was 
primarily conducted by AKF, in consultation with AOC. 
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(3) Results 
The Google search identified several hundred thousand sources; only the first two hundred 
were searched because after that they were irrelevant. 2,201 potential studies were identified, 
with 1,959 rejected on title (Figure. 1). Ten studies could not be retrieved despite attempts to 
contact the authors. Thirty-two studies were rejected on their abstract. Of the 200 studies 
retrieved for review, six were duplicates and 170 were rejected. Twenty-four studies met the 
inclusion criteria. 
 
3.1 Description of studies 
The 24 included studies were diverse in terms of their methodology and the service evaluated 
(Table 1). All but one of the studies was published in the last ten years, highlighting that 
social prescribing is a relatively recent phenomenon. One study was based in Ireland, with the 
remainder from the United Kingdom. Seventeen were reports and seven were journal articles. 
There were three discussion articles: Brandling and House (2009), Brown et al. (2004), and 
NESTA (2013) and four reviews: Friedli et al. (2009), Friedli (2007), Keenaghan et al. (2012) 
and Johnson and Ross (2011). These sought to inform the development of a specific social 
prescribing service rather than for the purpose of evidence synthesis. The remaining 17 
studies used a variety of primary research methods. Grant et al. (2000) was the only 
randomised controlled trial and cost-effectiveness analysis. Seven studies: Brandling et al. 
(2011), Friedli et al. (2012), Grayer et al. (2008), The Care Forum (2012), ERS (2013), Age 
UK (2012) and Dayson et al. (2013) considered effectiveness using a before and after design. 
Fourteen studies used qualitative methods including interviews and focus groups to describe a 
service and its perceived benefits and challenges. 
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3.2 Key components of social prescribing 
3.2.1 Recipients 
Several studies reported that social isolation and low mood due to life circumstances such as 
unemployment were the key reasons for referral to social prescribing (The Care Forum, 
2013). Social prescribing was considered suitable for frequent attendees to health services or 
those with inexplicable symptoms (NESTA, 2013). Services had inclusive referral criteria 
(Brandling et al., 2011). The literature did not explore why a patient was referred to social 
prescribing rather than mental health services. 
Patients using social prescribing services were largely female and over 40 years old. Some 
services were aimed at older patients (Age UK, 2012) but otherwise it was not clear why the 
clientele were older. Age UK (2012) found that referrals for black and ethnic minority 
patients were disproportionally low. Patients were from vulnerable groups: 37% of patients 
were unemployed/on long-term sick leave compared to the average of 5% in the area (The 
Care Forum, 2013).   
 
3.2.2 Referral pathways 
GPs and practice nurses were the main sources of referral (Woodall and South, 2005). 
Several services accepted self-referrals (South et al, 2008) or referrals from other sources 
including housing officers (Johnson and Ross, 2011). Referral pathways were often limited 
by service capacity (Brandling et al., 2011).   
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3.2.3 Referral rates 
Studies described a range of referral rates including 5 and 52 per month which reflected 
differences in service size (The Care Forum, 2013 and NHS Tayside, 2011). There were 
concerns about engaging sufficient demand due to a lack of referrals (Brandling et al., 2011) 
and because some patients did not engage with social prescribing (Faulkner, 2004 and 
McMahon, 2013).  
 
3.2.4 Appointments 
Patients were usually seen within four weeks (Grayer et al., 2008). Non-engagement rates 
were higher amongst patients who waited longer for an assessment (The Care Forum, 2013).  
Qualitative research identified that operating from General Practices legitimised services in 
the eyes of patients and health professionals (Brandling and House, 2009). Patients initially 
had a 40 to 90 minute long appointment to enable the social prescriber to identify needs and 
appropriate activities (Brandling et al, 2011). Patients then had a small number of follow-up 
appointments; for example, the modal number in Grant et al. (2000) was two. Woodall and 
South (2005) found that some patients valued initially being accompanied to activities.  
 
3.2.5 Prescriptions 
Patients were mainly prescribed hobbies, volunteering opportunities or befriending services 
(Dayson et al., 2013), with 58% of patients engaging in an activity (Grayer et al., 2008).   
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3.2.6 Resources utilised in the provision of social prescribing 
Social prescribers were usually employed by community organisations and were generic 
workers rather than having specific clinical qualifications (Keenaghan et al., 2012). There 
was little information on the running costs of these services. NHS Tayside (2011) estimated 
£27,300 annually per general practice, which provided support to six to eight patients a week. 
Services were often pilots or small scale, with unsecured funding (Johnson and Ross, 2011).  
 
3.3 Evidence on the impact of social prescribing 
3.3.1 Improvement in health and well-being 
Whilst all of the studies discussed the benefits of social prescribing, only some were 
substantiated with empirical evidence. Through qualitative interviews, Woodall and South 
(2005) found that patients perceived that social prescribing increased their self-esteem and 
self-efficacy because it enabled them to access appropriate help and develop their support 
networks.  
Eight studies used quantitative methods to explore changes in health and well-being. Grant et 
al. (2000) was the only randomised controlled trial and concluded that social prescribing has 
clinically important benefits in managing psychosocial needs compared to usual care. For 
example there was a statistically significant improvement in the Hospital Anxiety Scale at 
four months (Difference= -1.9, P value= .002). Five studies presented before and after data 
utilising a variety of outcome measures including the Warwick Edinburgh Mental Well Being 
Scale (WEMWBS) and General Health Questionnaire- 12  (Grayer et al., 2008, Brandling et 
al, 2011, Age UK, 2012, ERS, 2013 and The Care Forum, 2013). They found that, over a 
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range of time points up to a year, patients who received social prescribing experienced an 
improvement in their well-being, reduction in symptoms and met their goals. These results 
are available at: https://www.sheffield.ac.uk/scharr/sections/hsr/mcru/staff/foster.  
 
The quality of the quantitative studies was not high; often the findings were based on small 
samples, with large drop-out rates. For example, in Brandling et al. (2011), only 7/33 patients 
completed the WEMWBS at 6-12 months. There was little consideration about whether any 
change was statistically or clinically significant. 
 
3.3.2 Changes in health service use 
Health professionals in qualitative interviews reported that social prescribing reduced demand 
on primary care services (Involve North East, 2013). Other studies found that 82% of patients 
decreased their number of health professional consultations (Popay et al., 2007) and there 
was a reduction in medical prescriptions (Age UK, 2012). However, Grant et al. (2000) 
reported little decease in primary care use.  
 
3.3.3 Cost-effectiveness 
Social prescribing is promoted as potentially cost saving (NHS Tayside, 2011). However, the 
only cost-effectiveness analysis found social prescribing to be on average £20 more 
expensive per patient compared with usual care over a four month period (Grant et al., 2000). 
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3.3.4 Feasibility and acceptability 
Based on qualitative research, generally stakeholders viewed social prescribing as feasible 
and acceptable (Brandling and House, 2007 and Faulkner, 2004) and encompassing current 
policies on promoting self-management (Friedli, 2007). However the majority of referrals 
from social prescribing services were to community sector activities which raised capacity 
issues for some activities (Evans et al., 2013). Patients still faced practical barriers to 
engagement in activities such as cost or limited language skills (Johnson and Ross, 2011). 
 
(4) Discussion and Conclusion 
4.1 Discussion 
The review identified that stakeholders viewed social prescribing as acceptable and feasible, 
perceiving it as improving patient well-being and reducing use of health services. But there 
was limited quantitative evidence of effectiveness and only one robust evaluative design. 
This gap needs to be addressed because decision makers are increasingly prioritising funding 
to services that can demonstrate impact (Devlin and Appleby, 2010). This could be done in 
both research and routine practice contexts by increasing the use of standardised outcome 
measures, for example the WEMWBS, and by considering whether any changes measured 
are clinically significant. Further cost-effectiveness studies, over a longer time frame are 
needed because Grant et al. (2000) had marginal findings.  
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4.1.2 Limitations of the review 
No studies were identified from countries outside of the United Kingdom and Ireland. Whilst 
this could be a weakness of the search strategy, none of the included studies referenced 
relevant research from other countries. There is publication bias because ten studies could not 
be accessed despite attempts to contact the authors. To minimise the bias of the review 
primarily being conducted by one researcher, AKF regularly consulted with another 
researcher (AOC). There may be reporting bias because studies not finding an impact, may 
not have been published. 
 
4.2 Conclusion and implications 
This review identified a number of studies describing social prescribing and its potential 
impact. Stakeholders perceived that it LPSURYHGSDWLHQWV¶PHQWDOZHOO-being and reduced 
service use. However, due to the lack of high quality studies of effectiveness, further 
effectiveness and cost-effectiveness studies are needed. There is current interest in 
developing social prescribing (Dayson et al, 2013) and this review may help to develop and 
evaluate these services. Stakeholders need to collaborate to address the evidence gap 
identified here. Without this, given the current financial and policy climate, it will be 
challenging for social prescribing to develop beyond locally based short-term funded 
services.  
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Table 1- Description of the studies 
Author Year of 
Publication 
Country  Literature 
type 
Type of study Focus 
Age UK 2012 England Report Service 
evaluation 
Acceptability and feasibility of a social 
prescribing scheme in practice and 
description of users  
Brandling 
et al. 
 
2011 England Report Mixed 
methods 
including 
qualitative and 
outcome 
measures 
Acceptability and feasibility of a social 
prescribing scheme in practice and 
effectiveness of social prescribing using a 
before and after design 
Brandling 
and House 
 
2009 England Journal 
article 
Discussion 
article 
 Feasibility of social prescribing 
Brandling 
and House 
 
2007 England Report Qualitative 
study 
Acceptability and feasibility of a social 
prescribing scheme in practice 
Brown et 
al. 
2004 England Journal 
article 
Discussion 
article 
Feasibility of social prescribing 
Dayson et 
al. 
2013 England Report  Mixed method Acceptability and feasibility of a social 
prescribing scheme, 
Description of users and 
Effectiveness of social prescribing using a 
before and after design   
ERS 
 
2013 England Report Mixed method Acceptability and feasibility of a social 
prescribing scheme in practice and 
description of users 
Evans et al.  2011 England Report Mental well-
being impact 
assessment 
Acceptability and feasibility of a social 
prescribing scheme in practice 
Faulkner  2004 England Journal 
article 
Qualitative  Acceptability and feasibility of a social 
prescribing scheme in practice 
Friedli et 
al.  
2012 Scotland Report Mixed 
methods 
Acceptability and feasibility of a social 
prescribing scheme in practice, 
description of users and 
effectiveness of social prescribing using a 
before and after design   
Friedli et 
al.  
2009 England  Report Literature 
review 
Acceptability and feasibility of a social 
prescribing scheme in practice 
Friedli 2007 Scotland Report Literature 
review 
Acceptability and feasibility of a social 
prescribing scheme in practice  
Grant et al.  2000 England Journal 
article 
Randomised 
controlled trial 
and economic 
evaluation 
Effectiveness of social prescribing using an 
experimental design (Randomised Controlled 
Trial) and cost-effectiveness study  
 
Grayer et 
al.  
2008 England Journal 
article 
Before and 
after 
evaluation 
Effectiveness of social prescribing using a 
before and after design 
Involve 
North East 
 
2013 England Report Mixed method Acceptability and feasibility of a social 
prescribing scheme in practice 
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Johnson & 
Ross  
2011 England Report Literature 
review 
 Acceptability and feasibility of a social 
prescribing scheme in practice 
Keenaghan 
et al.  
2012 Ireland Report Literature 
review 
Acceptability and feasibility of a social 
prescribing scheme in practice 
McMahon  2012 Scotland Report Service 
evaluation 
Acceptability and feasibility of a social 
prescribing scheme in practice  
NESTA 2013 England Report Discussion 
article 
Feasibility of social prescribing 
NHS 
Tayside   
2011 Scotland Report Service 
evaluation 
 Acceptability and feasibility of a social 
prescribing scheme in practice and 
description of users 
Popay et al.   2007 England Journal 
article 
Questionnaire Feasibility of social prescribing  
South et al.   2008 England Journal 
article 
Qualitative Acceptability and feasibility of a social 
prescribing scheme in practice 
The Care 
Forum  
2012 England Report Service 
evaluation 
Acceptability and feasibility of a social 
prescribing scheme in practice and 
description of users 
Woodall & 
South  
2005 England Report Mixed 
methods 
Acceptability and feasibility of a social 
prescribing scheme in practice and 
description of users 
 
Figure. 1- Study Selection Diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Potentially relevant studies identified through the search and 
reference list scans: (n=2201) 
Studies excluded based on title: 
(n=1959) 
Full studies retrieved for further review: (n=200) 
Studies excluded based on full review: 
(n=170) 
Duplicates: (n=6) 
Studies that could not be retrieved: 
(n=10) 
Studies rejected on abstract: (n=32) 
Studies included in the review: (n=24) 
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